Get the Stockscreener App
0.00
100.00%
-0.0002
Effector Therapeutics Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
See More
Previous Close:
$0.0002
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
$-34.63M
P/E Ratio:
0.00
EPS:
-13.08
Net Cash Flow:
$-29.19M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-99.78%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$0.0002
Effector Therapeutics Inc Stock (EFTR) Company Profile
Name
Effector Therapeutics Inc
Sector
Industry
Phone
-
Address
-
Compare EFTR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EFTR
Effector Therapeutics Inc
|
0.00 | 0 | 0 | -34.63M | -29.19M | -13.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Effector Therapeutics Inc Stock (EFTR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-25-22 | Downgrade | Stifel | Buy → Hold |
| Nov-09-21 | Upgrade | Stifel | Hold → Buy |
| Oct-12-21 | Initiated | Credit Suisse | Outperform |
| Oct-04-21 | Initiated | Mizuho | Buy |
| Sep-21-21 | Initiated | JMP Securities | Mkt Outperform |
| Sep-20-21 | Initiated | Stifel | Hold |
| Sep-13-21 | Initiated | Cantor Fitzgerald | Overweight |
View All
Effector Therapeutics Inc Stock (EFTR) Latest News
Why eFFECTOR Therapeutics Inc. (LWK) stock gets analyst attentionInsider Buying & AI Enhanced Trading Signals - Newser
Is eFFECTOR Therapeutics Inc. (LWK) stock positioned for secular growth2025 Market Outlook & Long Hold Capital Preservation Tips - Newser
Why eFFECTOR Therapeutics Inc. (LWK) stock remains top ratedWeekly Stock Recap & Daily Profit Maximizing Tips - Newser
Is eFFECTOR Therapeutics Inc. (LWK) stock resilient in recession scenariosMarket Performance Summary & Risk Controlled Swing Alerts - Newser
Why eFFECTOR Therapeutics Inc. (LWK) stock is listed among top recommendations2025 Technical Patterns & Risk Managed Investment Signals - Newser
What consensus target says about eFFECTOR Therapeutics Inc. (LWK) stockJuly 2025 WrapUp & Real-Time Volume Trigger Notifications - Newser
How dovish Fed policy supports eFFECTOR Therapeutics Inc. (LWK) stockJuly 2025 Sector Moves & Stock Portfolio Risk Management - Newser
eFFECTOR Therapeutics, Inc. (EFTR) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
eFFECTOR Therapeutics, Inc. (EFTR) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
How eFFECTOR Therapeutics Inc. (LWK) stock gains from tech spending2025 Short Interest & Fast Gaining Stock Reports - newser.com
eFFECTOR Therapeutics (NASDAQ:EFTR) versus Evotec (OTCMKTS:EVTCY) Head to Head Review - Defense World
Why eFFECTOR Therapeutics Inc. (LWK) stock attracts wealthy investorsAnalyst Downgrade & Safe Capital Preservation Plans - newser.com
Will eFFECTOR Therapeutics Inc. (LWK) stock justify high valuationJuly 2025 Weekly Recap & Technical Pattern Based Buy Signals - newser.com
Effector Therapeutics Inc Stock (EFTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.44%
0.91%
Cap:
|
Volume (24h):